Literature DB >> 33928565

Experimental Autoimmune Encephalomyelitis.

Clara Ballerini1.   

Abstract

Experimental autoimmune encephalomyelitis, originally experimental allergic encephalomyelitis, is the well-known animal model of multiple sclerosis, an immune- mediated, demyelinating, inflammatory chronic disease of the central nervous system. The experimental disease is widely utilized to test new therapies in preclinical studies, to investigate new hypothesis on the possible pathogenic mechanisms of autoimmune reaction directed against the central nervous system or more generally to investigate the interactions between the immune system and the central nervous system that lead to neuroinflammation. The experimental autoimmune encephalomyelitis may be induced following different protocols in mammals, including nonhuman primates, and autoreactive CD4+ T-lymphocytes directed against myelin antigens are the main factors. Here, after introducing the model, we describe the protocol to induce active EAE in inbred mice, we report on a table the different clinical courses of EAE depending on the combination of antigen /mouse strain and we provide indications on how to evaluate the clinics and pathology of this induced disease.

Entities:  

Keywords:  Clinical course and scores; EAE protocols; Immunization technique; Mouse strains; Myelin antigens; Pathology

Year:  2021        PMID: 33928565     DOI: 10.1007/978-1-0716-1311-5_27

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

Review 1.  Doppler ultrasound in assessing systolic left ventricular function in cardiovascular patients.

Authors:  A M Salmasi; S Salmasi; A N Nicolaides
Journal:  Int Angiol       Date:  1990 Jan-Mar       Impact factor: 2.789

Review 2.  Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond.

Authors:  Markus Kipp; Baukje van der Star; Daphne Y S Vogel; Fabìola Puentes; Paul van der Valk; David Baker; Sandra Amor
Journal:  Mult Scler Relat Disord       Date:  2011-09-16       Impact factor: 4.339

3.  IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.

Authors:  Bruno Gran; Guang-Xian Zhang; Shuo Yu; Jifen Li; Xiao-Han Chen; Elvira S Ventura; Malek Kamoun; Abdolmohamad Rostami
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

Review 4.  T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire.

Authors:  Vijay K Kuchroo; Ana C Anderson; Hanspeter Waldner; Markus Munder; Estelle Bettelli; Lindsay B Nicholson
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

5.  Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis.

Authors:  M Sundvall; J Jirholt; H T Yang; L Jansson; A Engström; U Pettersson; R Holmdahl
Journal:  Nat Genet       Date:  1995-07       Impact factor: 38.330

6.  Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein.

Authors:  R B Fritz; C H Chou; D E McFarlin
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

7.  Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice.

Authors:  S Amor; N Groome; C Linington; M M Morris; K Dornmair; M V Gardinier; J M Matthieu; D Baker
Journal:  J Immunol       Date:  1994-11-15       Impact factor: 5.422

Review 8.  Animal models of Multiple Sclerosis.

Authors:  Claudio Procaccini; Veronica De Rosa; Valentina Pucino; Luigi Formisano; Giuseppe Matarese
Journal:  Eur J Pharmacol       Date:  2015-03-27       Impact factor: 4.432

9.  Transfer of allergic encephalomyelitis in rats by means of lymph node cells.

Authors:  P Y PATERSON
Journal:  J Exp Med       Date:  1960-01-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.